GATMX Mutual Fund

NAV$19.27

Fund Essentials - as of Mar 31, 2026

Net Assets
$10M
Expense Ratio
1.21%
Dividend Yield (Current)
1.71%
Holdings
282
Inception Date
Jan 31, 2008
Fund Family
Goldman Sachs Asset Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+12.33%
1 Year+27.30%
3 Year+21.29%
5 Year+11.87%
10 Year+10.61%

Asset Allocation

Stocks: 100.03%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
AZN:LNAstrazeneca Plc Adr2.34%
NOVN:SMNovartis Ag__02.28%
ASML:ASASML HOLDING NV2.17%
NESN:SMNestle SA - Common Cl N1.82%
ABBN:SMAbb Ltd1.47%
Top 10 Concentration: 16.37%Report Date: Mar 31, 2026
Download all 282 holdings for GATMX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.71%
Frequency
Annually
Latest Distribution
$0.39
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how GATMX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

GATMX Mutual Fund Overview

GATMX Mutual Fund (Goldman Sachs International Tax-Managed Equity Fund Class A) is managed by Goldman Sachs Asset Management with $10.1M in net assets. GATMX expense ratio is 1.21%, holding 282 positions across sectors including Unknown, Financials, Materials. Inception date: 2008-01-31.

GATMX performance shows a YTD return of 12.33%. The 1-year return is 27.30% and the 5-year return is 11.87%. GATMX dividend yield stands at 1.71%, paid annually.

GATMX top holdings include Astrazeneca Plc Adr (2.3%), Novartis Ag__0 (2.3%), ASML HOLDING NV (2.2%), Nestle SA - Common Cl N (1.8%), Abb Ltd (1.5%). View all GATMX holdings, sector breakdown, or dividend history.

GATMX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GATMX alternatives are available via the screener, along with tax-loss harvesting opportunities.